Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells (2017)
- Autores:
- Autor USP: BASSÈRES, DANIELA SANCHEZ - IQ
- Unidade: IQ
- Assuntos: NEOPLASIAS PULMONARES; MUTAÇÃO
- Idioma: Inglês
- Imprenta:
- Editora: Sociedade Brasileira de Bioquímica e Biologia Molecular/SBBq
- Local: São Paulo
- Data de publicação: 2017
- Fonte:
- Título do periódico: Abstracts
- Nome do evento: Annual Meeting of the Brazilian Society for Biochemistry and Molecular Biology
-
ABNT
RODRIGUES, F. S et al. Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells. 2017, Anais.. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular/SBBq, 2017. . Acesso em: 05 maio 2024. -
APA
Rodrigues, F. S., Carneiro Lobo, T. C., Scalabrini, L. C., & Bassères, D. S. (2017). Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells. In Abstracts. São Paulo: Sociedade Brasileira de Bioquímica e Biologia Molecular/SBBq. -
NLM
Rodrigues FS, Carneiro Lobo TC, Scalabrini LC, Bassères DS. Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells. Abstracts. 2017 ;[citado 2024 maio 05 ] -
Vancouver
Rodrigues FS, Carneiro Lobo TC, Scalabrini LC, Bassères DS. Exploring IKKβ kinase as a therapeutic target for KRAS-driven lung tumor initiating cells. Abstracts. 2017 ;[citado 2024 maio 05 ] - Aurora kinases: potential therapeutic targets in K-Ras-induced lung cancer
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression
- Exploring IKKβ as an anti-metastatic therapeutic target in KRAS-induced lung cancer
- Targeting Aurora A kinase activity in lung cancer initiating cells driven by oncogenic KRAS
- IKKβ inhibition suppresses sphere formation and self renewal of lung cancer initiating cells
- Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
- IKKβ kinase promotes stemness, migration, and invasion in KRAS-driven lung adenocarcinoma cells
- Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
- FOXO1 inhibition by oncogenic KRAS as an important mechanism promoting lung oncogenesis
- Requirement of the NF-'capa' B subunit p65/RelA for 'capa'-Ras-induced lung tumorigenesis
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
